A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis

Genetically engineered probiotics, able to in situ deliver therapeutically active compounds while restoring gut eubiosis, could represent an attractive therapeutic alternative in Clostridium difficile infection (CDI). Palmitoylethanolamide is an endogenous lipid able to exert immunomodulatory activi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Front Pharmacol
Päätekijät: Esposito, Giuseppe, Corpetti, Chiara, Pesce, Marcella, Seguella, Luisa, Annunziata, Giuseppe, Del Re, Alessandro, Vincenzi, Martina, Lattanzi, Roberta, Lu, Jie, Sanseverino, Walter, Sarnelli, Giovanni
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2021
Aiheet:
Pharmacology
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8111445/
https://ncbi.nlm.nih.gov/pubmed/33986673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2021.639728
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia